Vaxcyte, Inc. PCVX Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s operating cash flow?
- Vaxcyte, Inc. (PCVX) reported operating cash flow of -$280.63M in Q1 2026.
- How has Vaxcyte, Inc.'s operating cash flow changed year-over-year?
- Vaxcyte, Inc.'s operating cash flow decreased by 68.8% year-over-year, from -$166.27M to -$280.63M.
- What is the long-term trend for Vaxcyte, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Vaxcyte, Inc.'s operating cash flow has grown at a 52.4% compound annual growth rate (CAGR), from -$121.39M to -$655.58M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.